42 results
6-K
EX-99.7
AMYT
Amryt Pharma Plc
3 Nov 22
Current report (foreign)
7:44am
. Performance conditions determine how many of these performance stock units will vest and, if performance targets are exceeded, additional performance … targets may occur may change. Such changes may have a material impact on the assessment of the expected cash flows of the CVRs.
Amryt reviews
6-K
EX-99.5
AMYT
Amryt Pharma Plc
4 Aug 22
Results of Annual General Meeting
7:38am
units will vest and, if performance targets are exceeded, additional performance stock units will be issued and vest in accordance with the terms … (i.e. regulatory requirements and the commercial success of the product), the timing of when such revenue targets may occur may change. Such changes
424B3
AMYT
Amryt Pharma Plc
4 May 22
Prospectus supplement
8:35am
targets are exceeded, additional performance stock units will be issued and vest in accordance with the terms of the relevant performance stock units … to zero if before July 1, 2022
Revenue targets
US$35,000,000 upon Oleogel-S10 revenues exceeding US$75,000,000 in any 12-month period prior to June 30
424B3
AMYT
Amryt Pharma Plc
4 May 22
Prospectus supplement
7:45am
targets are exceeded, additional performance stock units will be issued and vest in accordance with the terms of the relevant performance stock units … of the product), the timing of when such revenue targets may occur may change. Such changes may have a material impact on the assessment of the expected
6-K
EX-99.1
AMYT
Amryt Pharma Plc
4 May 22
Amryt Reports Record Q1 2022 Results
7:43am
period to March 31, 2022. Performance conditions determine how many of these performance stock units will vest and, if performance targets are exceeded … such revenue targets may occur may change. Such changes may have a material impact on the assessment of the expected cash flows of the CVRs.
Amryt
424B3
87y89uwicaqaf6
9 Mar 22
Prospectus supplement
9:26am
424B3
7zcjsx
9 Mar 22
Prospectus supplement
9:25am
6-K
EX-99.1
43d3x9derqr91g7l0k
9 Mar 22
Amryt Announces 22% growth in FY 2021 Revenues to $222.5M
9:23am
424B3
1dfp6gxjhj4hjws5f93c
22 Nov 21
Prospectus supplement
7:39am
424B3
z0d lbcc31p
22 Nov 21
Prospectus supplement
7:38am
6-K
EX-99.3
kw2wil
22 Nov 21
Amryt Announces the Cancellation of Admission of its Ordinary Shares to Trading on AIM
7:37am
424B3
eb14 rt53u
3 Nov 21
Prospectus supplement
7:33am
424B3
ved c5igen
3 Nov 21
Prospectus supplement
7:32am
6-K
EX-99.1
noxuwk tq1b14vuw54l
3 Nov 21
Amryt Reports Strong Q3 2021 Results
7:31am
6-K
EX-99.2
tddt0 yxneh
13 Sep 21
Current report (foreign)
8:48am
6-K
EX-99.1
jbuj3l
6 Aug 21
Amryt Reports Record Q2 2021 Results and Raises FY 2021 Guidance
8:18am
424B3
dy3mx6yxdwbuudh
6 Aug 21
Prospectus supplement
8:18am
424B3
rlnw3fkt
6 Aug 21
Prospectus supplement
8:17am
424B3
a812t3
1 Jul 21
Prospectus supplement
5:20pm